Silver Spring, MD, United States of America

Jeffrey A Torestsky

This inventor holds 1 USPTO granted patent and 1 published patent application. Top assignee: Georgetown University. Active years: 2016.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Jeffrey A Torestsky. Retrieved from https://idiyas.com/inventor/jeffrey-a-torestsky

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

USPTO Granted Patents = 1 

% Patents Active = 100.0

Average Co-Inventor Count = 6.0

ph-index = 1

Forward Citations = 1(Granted Patents)


Company Filing History:


Years Active: 2016

Loading Chart...
1 patent (USPTO):Explore Patents

Title: The Innovations of Jeffrey A. Torestsky

Introduction

Jeffrey A. Torestsky is an accomplished inventor based in Silver Spring, MD. He has made significant contributions to the field of pharmaceuticals, particularly in the development of compounds that target cancer cells. His innovative work has led to the creation of a patent that holds promise for cancer treatment.

Latest Patents

Torestsky's most notable patent is focused on Ezrin inhibitors and methods of making and using them. This invention encompasses a compound and pharmaceutical composition that includes a specific formula, which is useful for inhibiting the ezrin protein in a cell. The patent also addresses the inhibition of cancer cell growth, showcasing Torestsky's commitment to advancing medical science.

Career Highlights

Jeffrey A. Torestsky is affiliated with Georgetown University, where he continues to engage in research and development. His work at the university allows him to collaborate with other experts in the field, further enhancing his contributions to innovation in pharmaceuticals.

Collaborations

Torestsky has worked alongside notable colleagues, including Milton L. Brown and Mikell Paige. These collaborations have enriched his research and have been instrumental in the development of his patented inventions.

Conclusion

Jeffrey A. Torestsky's innovative work in developing Ezrin inhibitors represents a significant advancement in cancer treatment. His contributions to the field of pharmaceuticals highlight the importance of research and collaboration in driving medical innovation.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…